Cardiovascular Implants Market Report 2026

Cardiovascular Implants Market Overview

• Cardiovascular Implants market size has reached to $28.68 billion in 2025 • Expected to grow to $39.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Prevalence Of Heart Disorders • Market Trend: Increasing Focus On Adopting Advanced Technology With Artificial Intelligence (AI) To Maximize Profit • North America was the largest region in 2025.

What Is Covered Under Cardiovascular Implants Market?

Cardiovascular implants refer to medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These are inserted into the cardiovascular system to treat conditions such as blocked arteries, irregular heart rhythms, or valve defects, restoring normal heart function and improving blood circulation. The main types of products included in cardiovascular implants are coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to help keep it open. The materials used are metals and alloys, polymers, and biological materials. and are used for various applications, including arrhythmias, acute myocardial infarction, myocardial ischemia, and others, by numerous end-users, such as hospitals, ambulatory surgical centers, and cardiac centers.

What Is The Cardiovascular Implants Market Growth Forecast?

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $39.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive cardiac treatments, expansion of structural heart disease therapies, growing focus on personalized cardiovascular care, increasing innovation in implant materials and designs. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular implants, rising use of drug-eluting and bioabsorbable stents, growing preference for transcatheter heart valve procedures, expansion of advanced cardiac rhythm management devices, enhanced focus on long-term implant durability.

Global Cardiovascular Implants Market Segmentation

1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent 2) By Material: Metals and Alloys, Polymers, Biological Materials 3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications 4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers Subsegments: 1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents 2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD 3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves 4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker 5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators) 6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents

What Is The Driver Of The Cardiovascular Implants Market?

The rising prevalence of heart disorders is expected to propel the growth of the cardiovascular implants market going forward. Heart disorders refer to various medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valve disorders. The prevalence of heart diseases, such as coronary artery disease and heart failure, drives the demand for cardiovascular implants, including stents and pacemakers, to treat these conditions. These implants support the heart and circulation in patients with heart failure, help the heart beat in a regular rhythm, and keep track of the heart rhythm. For instance, in September 2024, according to a report published by the British Heart Foundation (BHF), a UK-based charity that funds research and raises awareness about heart and circulatory diseases, approximately 7.6 million individuals in the UK are affected by heart and circulatory diseases. By 2030, the number of people living with heart and circulatory diseases in the UK could increase by 1 million, and by 2040, this figure may rise by 2 million, an addition to the present figures. Therefore, the rising prevalence of heart disorders is driving the growth of the cardiovascular implants industry.

Key Players In The Global Cardiovascular Implants Market

Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd

Global Cardiovascular Implants Market Trends and Insights

Major companies operating in the cardiovascular implants market are increasing their focus on adopting advanced technology with artificial intelligence (AI) to maximize their profits in the market and enhance patient care and treatment precision. The advancement of cardiac monitoring technology refers to continuously tracking and recording a patient's heart activity to diagnose and manage heart conditions. For instance, in June 2023, BIOTRONIK SE & Co. KG, a Germany-based medical technology company, launched the first global implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). BIOMONITOR IV is a cutting-edge ICM that combines BIOTRONIK's SmartECG technology with artificial intelligence to cut false-positive detections by 86% while retaining 98% of real episodes. In addition to the sophisticated artificial intelligence, there are several other advantages for patients and healthcare professionals who use BIOMONITOR IV. Lengthy battery life and wireless connectivity provide smooth data transmission and remote monitoring, decreasing the need for frequent in-person clinic visits.

What Are Latest Mergers And Acquisitions In The Cardiovascular Implants Market?

In April 2023, Abbott Laboratories, a US-based healthcare company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition provides Abbott with a complementary solution for treating vascular disease. Through this transaction, CSI became a wholly owned subsidiary of Abbott. Cardiovascular Systems Inc. is a US-based manufacturer of cardiovascular implants and offers innovative solutions for treating peripheral and coronary vascular disease.

Regional Outlook

North America was the largest region in the cardiovascular implants market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cardiovascular Implants Market?

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.